Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema
associated with rosacea. The study hypothesis is that CD07805/47 gel, applied topically once
daily is more efficacious than vehicle and provides an acceptable safety profile in the
treatment of facial erythema associated with rosacea